Vol. 8, Issue 9 (2019)

Author(s):
Ashok Bishnoi and Mahesh K Vyas

Abstract:
Ayurvedic formulations are highly effective and known to have minimal side effects, but due to lack of validation parameters for identification and quality control, there is a lacuna in demand of Ayurvedic formulations at international level. Saraswata Churna is an classical Ayurvedic formulation used in the treatment of psychosomatic disorders, loss of memory etc. The objective of the work is to formulate and standardize the Saraswata Churna according to World Health Organization (WHO), GMP guidelines which are the first available report so far. The formulation was prepared in the pharmacy of IPGT& RA, Jamnagar and evaluated for organoleptic characters, powder drug studies, physicochemical parameters (Loss in drying, ash value, acid soluble extract, water soluble extract, pH value), High Performance Thin Layer Chromatography. The results of different standardization parameters revealed satisfactory and sufficient data to evaluate the in- house formulation and can be utilized as reference standards in various quality control aspects of the formulation, powder drug analysis revealed specific identities for crude raw drug which are useful as marker in the preparation and identification of components of the formulation.